MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm
Orthostatic myoclonus after brain tumor surgery and radiation

J. Cutsforth-Gregory, J. Hammack, J. Matsumoto (Rochester, MN, USA)

Myoclonus  ·  Exhibit Hall C
1:15pm-2:45pm
Oscillatory dynamics of impaired novelty detection at early Parkinson’s disease

R. Solis-Vivanco, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico City, Mexico)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
Othello syndrome amongst patients with Parkinson’s disease in a rural movement disorders clinic in western India

S. Desai, D. Desai (Anand, India)

Parkinson's Disease: Psychiatric Manifestations  ·  Exhibit Hall C
1:15pm-2:45pm
Parkin (PARK 2) Mutations in Patients with Early-Onset Parkinson’s Disease

A. Ivashynka, S. Likhachev (Minsk, Belarus)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Parkinson’s disease in untreated Gaucher patients is associated with reduced glucosylsphingosine (Lyso-Gb1) serum levels

D. Arkadir, T. Dinur, A. Rolfs, A. Zimran (Jerusalem, Israel)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Parkinson’s disease subtypes correlate with clinical severity: a Brazilian population study

C. Batista, M. Medeiros, C. Rieder, A. Schuh (Porto Alegre, Brazil)

Phenomenology and Clinical Assessment Of Movement Disorders  ·  Exhibit Hall C
1:15pm-2:45pm
Parkinson’s disease GWAS risk loci and symptom progression

K. Paul, J. Schulz, J. Bronstein, C. Lill, B. Ritz (los angeles, CA, USA)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Parkinsonian Features in a Cohort of Gaucher’s Disease (GD) Patients and Relatives.

I. Trezzi, E. Monfrini, G. Buongarzone, E. Cassinerio, I. Motta, F. Nascimbeni, F. Carubbi, N. Bresolin, G. Comi, M. Cappellini, A. Di Fonzo (Milan, Italy)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Patient-derived GBA1-PARK2 double-mutant cellular models to study the effect of GBA1 as a modifier of familial Parkinson’s disease

Z. Hanss, I. Boussaad, P. Barbuti, S. Goldwurm, R. Krüger (Belvaux, Luxembourg)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Patient-reported hallucinations and the probability of progression to dementia in Parkinson’s disease

K.-L. Horne, D. Myall, M. MacAskill, L. Livingston, S. Grenfell, T. Melzer, T. Pitcher, T. Anderson, J. Dalrymple-Alford (Christchurch, New Zealand)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 38
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley